Home » Topics » Regulatory

Regulatory
RSS

Oral human immunoglobulin enters clinic for severe RA

June 13, 1997

Testosterone transdermal patch now available in the U.S. in a once-daily formulation

June 13, 1997

Carvedilol and its metabolite attenuate Hb-mediated neuronal injury

June 13, 1997

ACE inhibitors for diabetes

June 13, 1997

Mylan files ANDA for generic nifedipine

June 12, 1997

Transdermal buspirone patch shows encouraging results in ADHD

June 9, 1997

IVIg for acute cardiomyopathy

June 9, 1997

Generic aciclovir approved by FDA

June 9, 1997

Aciclovir demonstrates antiasthmatic activity in animal model

June 9, 1997

First approval for new MRI contrast agent from Nycomed

June 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...